News Register today! Vetting the Vendors: Ensuring your product contract service providers are your partners: protecting your asset and your relationship! Some of the most common services sought after by early stage healthcare and life science companies are the following: 1.…Super UserNovember 11, 2019
News Inside Johns Hopkins’ $17 Million Center for Psychedelic and Consciousness Research | Your EDM Johns Hopkins is getting involved with the vast and swiftly growing field of psychedelic research. The prestigious university is throwing down $17…Super UserNovember 11, 2019
News Top execs from AstraZeneca, Roche, Sanofi and GSK tout China investments at import expo | FiercePharma CEO Pascal Soriot knows what’s at stake for AstraZeneca’s business. It is whether China, now the British drugmaker’s second-largest market,…Super UserNovember 11, 2019
News Jay Perman best choice for USM chancellor – Baltimore Sun Just a year after I arrived at UMBC as a young vice provost in 1987, what we now know today…Super UserNovember 11, 2019
News Jay Perman to become chancellor of University System of Maryland – The Washington Post A pediatric gastroenterologist who is the veteran president of the University of Maryland at Baltimore was named Thursday to become…Super UserNovember 11, 2019
News Johns Hopkins Digital Health Day: Health Tech Frontiers Tickets, Wed, Nov 13, 2019 at 10:00 AM | Eventbrite Keynote: Rebecca Canino of Johns Hopkins Office of Telemedicine Digital Health inventors and innovators are invited to discover novel technologies…Super UserNovember 11, 2019
News Biotech Dilemma: The Race for Research and Lab Space | New Haven BIZ The New Haven area has become a hub for thriving and growing young bioscience companies like Arvinas and Cybrexa Therapeutics,…Super UserNovember 11, 2019
News AstraZeneca to Create $1B Fund, R&D Centers in China AstraZeneca said today it will create new R&D centers focused on drug development and artificial intelligence (AI) in Shanghai, as…Super UserNovember 11, 2019
News Cartesian Initiates CAR-T Clinical Trial in Myasthenia Gravis – Cartesian Gaithersburg, MD, November 5, 2019 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for…Super UserNovember 11, 2019
News Here’s Why the First Cure for HIV Could Emerge from Maryland · BioBuzz For those that lived through the devastation and horror of the HIV/AIDS epidemic of the early 1980s, effective treatment, let…Super UserNovember 11, 2019